
PTGX Technical Analysis Summary (NASDAQ)
Analyze PTGX on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerPTGX Technical Analysis Summary (NASDAQ)
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stock currently shows a bearish trend on the NASDAQ, supported by momentum and weak buying pressure.
Technical conditions suggest Protagonist Therapeutics, Inc. on the NASDAQ is awaiting a decisive move. Overall, Protagonist Therapeutics, Inc. remains neutral, with indicators showing mixed momentum.
RSI (14): 39.26
Stochastic %K: 30.33
Williams %R: -80.80
Rate of Change (ROC): -6.26
Takeaway:Protagonist Therapeutics, Inc. shows strong bearish momentum, signaling downside pressure.
MACD: -1.87
ADX: 21.72
ATR (14): 5.85
CCI (14): -108.98
Takeaway:Protagonist Therapeutics, Inc. shows oversold trend conditions, with potential for rebound if buyers step in.
Takeaway:Protagonist Therapeutics, Inc. trades closer to support, showing weaker momentum within bands.
Takeaway:Protagonist Therapeutics, Inc. trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:PTGX shows mixed signals in money flow analysis.
Bullish Signals
ADX above 20 → strong underlying trend.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Protagonist Therapeutics, Inc. shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.